Assignee
EPICS THERAPEUTICS
BE·6 granted patents·2 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
8 records- 0168US11072582B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2020·Granted Jul 27, 2021·0 cites·25 claims
- 0268US10781171B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2020·Granted Sep 22, 2020·0 cites·1 claims
- 0367US10577318B2Substituted pyrrolidines as G-protein coupled receptor 43 agonistsEPICS THERAPEUTICS·Filed 2019·Granted Mar 3, 2020·0 cites·1 claims
- 0466US12091400B2Piperidine derivatives as METTL3 inhibitorsEPICS THERAPEUTICS·Filed 2024·Granted Sep 17, 2024·0 cites·17 claims
- 0566US2025002475A1Piperidine derivatives as mettl3 inhibitorsEPICS THERAPEUTICS·Filed 2024·Application pending·0 cites
- 0665US2024294472A1Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereofEPICS THERAPEUTICS·Filed 2024·Application pending·0 cites
- 0764US12054457B2Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereofEPICS THERAPEUTICS·Filed 2023·Granted Aug 6, 2024·0 cites·15 claims
- 0855US12528769B2Synthesis of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acidEPICS THERAPEUTICS·Filed 2021·Granted Jan 20, 2026·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →